Helminthiasis
📧 Sign up to get email alerts when something new happens for Helminthiasis.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2026-02-13Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 February 2026
PRAC has concluded its safety review of levamisole, a medicine used to treat helminthiasis, and will issue further communications on safety …
-
EMA safety_alert · 2025-09-05PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections
The EMA's safety committee (PRAC) has opened a safety review of levamisole, used to treat parasitic worm infections, to evaluate the potenti…
-
EMA safety_alert · 2025-09-05Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September 2025
PRAC has begun a safety review of levamisole, used to treat parasitic worm infections.